Capital Flow Monitor · Sponsors · CIK 1843308
DexCare, Inc.
1522 Western Ave., #24336, SEATTLE, WA, 98101 · 253-302-8469
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$22.7M
Sold
$12.9M
% sold
56.9%
Investors
14
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | D ·current | 506(b) | $22.7M | $12.9M | 56.9% | 14 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Matthew Blosl — Executive Officer / Director, Seattle, WA
-
Lynne Chou O'Keefe — Director, Seattle, WA
1 other raise
- 9AMHEALTH INC. $25.7M of $25.7M · 100.0%
- Toby Cosgrove — Director, Seattle, WA
-
Todd Cozzens — Director, Seattle, WA
8 other raises
- Transformation Capital Executive Fund IV, L.P. $0 of —
- Golden Eagle Opportunities, L.P. $0 of —
- Alaffia Technology Solutions, Inc. $40.0M of $40.0M · 100.0%
- Transformation Capital Partners III-CPRX, L.P. $0 of —
- TRANSFORMATION CAPITAL CO-INVESTMENT FUND III, L.P. $15.7M of —
- Transformation Capital Fund IV-A, L.P. $0 of —
- Transformation Capital Fund IV, L.P. $0 of —
- Transformation Capital Fund IV (Cayman Feeder), L.P. $0 of —
-
Branden Fini — Director, Seattle, WA
1 other raise
- Greater Good Healthcare Inc. $17.6M of $20.6M · 85.5%
- Paul Minardi — Director, Seattle, WA
-
Caroline Xie — Director, Seattle, WA
1 other raise
- Twin Health, Inc. $59.0M of $61.5M · 95.9%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.